$8.9 B

BIO Mkt cap, 22-Jun-2018

$551.5 M

Bio-Rad Revenue Q1, 2018
Bio-Rad Gross profit (Q1, 2018)302.2 M
Bio-Rad Gross profit margin (Q1, 2018), %54.8%
Bio-Rad Cash, 31-Mar-2018407.3 M

Bio-Rad Financials

Bio-Rad Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

2.1 b2.2 b2 b2.1 b

Revenue growth, %

2%(7%)2%

Cost of goods sold

897.8 m930.1 m

Gross profit

1.1 b1.1 b

Gross profit Margin, %

56%55%

EBIT

166.7 m53.2 m

EBIT margin, %

8%3%

Interest expense

21.7 m21.9 m

Pre tax profit

145.8 m41.6 m

Income tax expense

(32.8 m)(13.4 m)

Net Income

77.8 m88.8 m113.1 m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

505.1 m509.3 m536.8 m530.6 m472.8 m506.1 m470 m471.2 m516.8 m508.7 m500.1 m504.7 m551.5 m

Cost of goods sold

220.9 m234.1 m239.6 m242.1 m202.7 m226.5 m206.5 m207.2 m236.5 m229.3 m230.1 m231.4 m249.3 m

Gross profit

284.2 m275.3 m297.2 m288.6 m270.1 m279.6 m263.5 m264 m280.2 m279.5 m270 m273.3 m302.2 m

Gross profit Margin, %

56%54%55%54%57%55%56%56%54%55%54%54%55%

R&D expense

49.4 m

General and administrative expense

209.1 m

Operating expense total

258.6 m

Interest expense

31.6 m3.9 m5.6 m7.7 m5 m4.8 m5.8 m5.6 m5.6 m5.6 m5 m5.8 m5.8 m

Pre tax profit

(5.2 m)14.5 m48.8 m22.5 m26.7 m39.5 m25.4 m20.2 m26.9 m22.7 m20.1 m1.1 m863.7 m

Income tax expense

(1.9 m)(7.9 m)(17.2 m)(11 m)(8.9 m)(11.1 m)(8 m)(7.9 m)(8.9 m)(4.3 m)(7.7 m)3.9 m(206.9 m)

Net Income

(7.1 m)6.7 m31.6 m11.5 m17.8 m28.4 m17.4 m12.3 m30.3 m48.7 m12.4 m17.4 m

Bio-Rad Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

331.6 m413.3 m457.5 m456.3 m

Inventories

525 m

Current Assets

1.7 b1.7 b1.8 b1.8 b

PP&E

429.4 m428.8 m437.7 m488.6 m

Total Assets

3.4 b3.3 b3.7 b3.9 b

Accounts Payable

148.5 m128.6 m122.4 m133.1 m

Current Liabilities

487.5 m446.8 m441.4 m471.3 m

Total Liabilities

1.3 b

Common Stock

2 k2 k2 k2 k

Additional Paid-in Capital

240 m271.3 m300.4 m332.9 m

Retained Earnings

1.6 b1.7 b1.8 b1.8 b

Total Equity

2.2 b2.2 b2.5 b2.6 b

Financial Leverage

1.5 x1.5 x1.5 x1.5 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

291.8 m364.5 m384.7 m424.6 m425.7 m450.1 m507.3 m403.6 m418.7 m417.9 m291.7 m321.6 m407.3 m

Accounts Receivable

383.5 m383.9 m378.9 m354.4 m342.2 m354.2 m341.5 m381.1 m366.3 m367.7 m373.4 m392.8 m430.4 m

Inventories

523.5 m513.9 m520.6 m516 m478.4 m501 m512.7 m533.3 m541.5 m556.4 m559.8 m580.6 m612.2 m

Current Assets

1.7 b1.8 b1.8 b1.8 b1.7 b1.7 b1.8 b1.8 b1.8 b1.9 b1.7 b1.8 b2 b

PP&E

425.1 m430.9 m440.3 m420.9 m428.3 m439.6 m433.8 m449.2 m457.7 m474.7 m505.1 m503.3 m499.7 m

Total Assets

3.3 b3.4 b3.5 b3.4 b3.3 b3.5 b3.7 b3.8 b3.9 b4 b4 b4.1 b6.2 b

Accounts Payable

131.9 m130.9 m125.5 m126.6 m

Current Liabilities

462.9 m481.3 m480.2 m503.8 m416.9 m403.9 m435.2 m400.9 m410.4 m442.7 m407.5 m455.1 m456.2 m

Total Liabilities

1.2 b1.2 b1.2 b1.2 b1.1 b1.2 b1.2 b1.2 b1.3 b1.3 b1.2 b1.3 b1.7 b

Common Stock

2 k2 k2 k2 k2 k2 k2 k2 k2 k2 k2 k2 k2 k

Additional Paid-in Capital

232 m247.3 m254.3 m259.9 m278.4 m285.7 m291.9 m308.9 m316.8 m324.6 m342.6 m347.7 m371 m

Retained Earnings

1.6 b1.6 b1.6 b1.7 b1.7 b1.7 b1.8 b1.8 b1.8 b1.9 b1.8 b1.9 b4 b

Total Equity

2.1 b2.2 b2.2 b2.2 b2.2 b2.4 b2.4 b2.5 b2.6 b2.7 b2.7 b2.8 b4.5 b

Financial Leverage

1.5 x1.5 x1.5 x1.6 x1.5 x1.5 x1.5 x1.5 x1.5 x1.5 x1.5 x1.5 x1.4 x

Bio-Rad Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

77.8 m88.8 m113.1 m

Cash From Operating Activities

175.5 m273.3 m186.2 m216.4 m

Cash From Investing Activities

(5.4 m)(190.5 m)(166.9 m)(213.9 m)

Cash From Financing Activities

(311.7 m)11.7 m8.6 m9 m

Interest Paid

(61.2 m)(20.8 m)(20.8 m)(21.3 m)

Free Cash Flow

288.5 m394.3 m298.2 m75 m

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

31.6 m11.5 m17.8 m28.4 m17.4 m12.3 m30.3 m48.7 m12.4 m

Accounts Receivable

378.9 m354.4 m342.2 m354.2 m341.5 m381.1 m366.3 m367.7 m373.4 m

Accounts Payable

125.5 m126.6 m

Cash From Operating Activities

40.3 m

Cash From Investing Activities

(18.8 m)

Cash From Financing Activities

2.5 m

Free Cash Flow

13.2 m

Bio-Rad Ratios

USDY, 2018

Financial Leverage

1.4 x
Report incorrect company information